Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot
M. J. Hartnett, Michele A. Lloyd-Puryear, Norma P. Tavakoli, et al.
International Journal of Neonatal Screening (2022) Vol. 8, Iss. 4, pp. 50-50
Open Access | Times Cited: 16

Showing 16 citing articles:

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
Bradford L. Therrell, Carmencita D. Padilla, Gustavo Borrajo, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 38-38
Open Access | Times Cited: 26
Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study
Norma P. Tavakoli, Dorota Gruber, Niki Armstrong, et al.
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 8, pp. 1383-1396
Open Access | Times Cited: 17
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium
Tamara Dangouloff, Kristine Hovhannesyan, Davood Mashhadizadeh, et al.
Children (2024) Vol. 11, Iss. 8, pp. 926-926
Open Access | Times Cited: 4
Current Concept Review: Orthopaedic Management in Duchenne Muscular Dystrophy
Uma Balachandran, Taylor Mustapich, Sheena C. Ranade
Journal of the Pediatric Orthopaedic Society of North America (2025), pp. 100154-100154
Open Access
Unraveling the Genetic Heartbeat: Decoding Cardiac Involvement in Duchenne Muscular Dystrophy
Valeria Novelli, Francesco Canonico, Renzo Laborante, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 102-102
Open Access
Quantification and comparison of anti-AAV9 and anti-AAVrh74 antibodies in plasma and human milk: Implications for AAV-based gene therapy candidacy
Carmen Leon‐Astudillo, Kirsten E. Coleman, Stephanie Salabarria, et al.
Journal of Neuromuscular Diseases (2025)
Closed Access
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy
Dorota Gruber, Michele A. Lloyd-Puryear, Niki Armstrong, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 2, pp. 197-205
Open Access | Times Cited: 16
Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications
Eugenio Mercuri, Marika Pane, Gianpaolo Cicala, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 10
Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina
Katerina S. Kucera, Beth Lincoln Boyea, Brooke Migliore, et al.
Genetics in Medicine (2023) Vol. 26, Iss. 1, pp. 101009-101009
Open Access | Times Cited: 9
The Early Care (0–3 Years) In Duchenne Muscular Dystrophy Meeting Report
Niki Armstrong, Susan Apkon, Kiera N. Berggren, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 525-533
Open Access | Times Cited: 2
Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy
Breanne Maloney, Sunju Park, Mycroft Sowizral, et al.
Clinical Biochemistry (2023) Vol. 118, pp. 110614-110614
Open Access | Times Cited: 5
Multi-Laboratory Evaluation of Prototype Dried Blood Spot Quality Control Materials for Creatine Kinase-MM Newborn Screening Assays
Paul Dantonio, Norma P. Tavakoli, Brooke Migliore, et al.
International Journal of Neonatal Screening (2023) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 3
Mathematical modeling of the progression of Duchenne Muscular Dystrophy in San Diego in an era of allele specific oligonucleotide therapy
Stephen F. Kingsmore, Dominic Baun, Laura Tobin, et al.
Research Square (Research Square) (2024)
Open Access
Age-Related Blood Levels of Creatine Kinase-MM in Newborns and Patients with Duchenne Muscular Dystrophy: Considerations for the Development of Newborn Screening Algorithms
Sarah Nelson Potter, Brooke Migliore, Javan K. Carter, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 41-41
Open Access
The use of the drug ataluren for the treatment of patients with Duchenne muscular dystrophy in real clinical practice
Sofia G. Popovich, Ludmila M. Kuzenkova, Evgeniya V. Uvakina, et al.
L O Badalyan Neurological Journal (2024) Vol. 5, Iss. 2, pp. 79-89
Closed Access
Charting the Ethical Frontier in Newborn Screening Research: Insights from the NBSTRN ELSI Researcher Needs Survey
Yekaterina Unnikumaran, Mei Lietsch, Amy Brower
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 64-64
Open Access
Page 1

Scroll to top